EX-21.1 5 lgnd123119exhibit211.htm EX-21.1
Exhibit 21.1
LIGAND PHARMACEUTICALS INCORPORATED
LIST OF SUBSIDIARIES

Name |  | Jurisdiction of Incorporation
Ab Initio Biotherapeutics, Inc. |  | Delaware
Adjacent Acquisition Co., LLC |  | Delaware
Glycomed Incorporated |  | California
Allergan Ligand Retinoid Therapeutics, Inc. |  | Delaware
Ligand Pharmaceuticals International, Inc. |  | Delaware
Ligand Biopharmaceuticals Incorporated |  | Delaware
Ligand JVR, Inc. |  | Delaware
Ligand Pharmaceuticals UK Limited |  | United Kingdom
Ligand Pharmaceuticals (Canada) Incorporated |  | Canada
Seragen Incorporated |  | Delaware
Seragen Technology, Inc. |  | Delaware
Pharmacopeia, LLC |  | Delaware
Metabasis Therapeutics, Inc. |  | Delaware
Neurogen Corporation |  | Delaware
CyDex Pharmaceuticals, Inc. |  | Delaware
Open Monoclonal Technology, Inc. |  | Delaware
OMT I, Inc. |  | Delaware
OMT II, Inc. |  | Delaware
Crystal Bioscience, Inc. |  | California
Vernalis plc |  | England and Wales
Vernalis (R&D) Limited |  | England and Wales
Vernalis Group Limited |  | England and Wales
Vernalis Therapeutics Inc. |  | Delaware
Vernalis (Canada) Inc. |  | Canada
Vernalis (Canada II) Inc. |  | Canada
Vernalis Development Limited |  | England and Wales
Vernalis Research Limited |  | England and Wales
Cita NeuroPharmaceuticals Inc. |  | Canada